Trial Profile

A Pilot Randomized Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase(PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 08 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MVI 816 (Primary) ; Granulocyte-macrophage colony-stimulating factors
Indications Prostate cancer
Focus Therapeutic Use

Most Recent Events

08 Mar 2019 Status changed from active, no longer recruiting to completed.
17 Apr 2013 Planned end date changed from 1 Mar 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.
16 Feb 2013 Results presented at the 2013 Genitourinary Cancers Symposium.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com